Form of S-omeprazole

CAFC
  • US 7,745,466 B2
  • Filed: 09/11/2007
  • Issued: 06/29/2010
  • Est. Priority Date: 05/30/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical composition comprising a first and second active ingredient and a pharmaceutically acceptable carrier, wherein the first active ingredient is the magnesium salt of S-omeprazole trihydrate, and wherein the second active ingredient is selected from the group consisting of anti-bacterial compounds, non-steroidal anti-inflammatory agents, antacid agents, alginates and prokinetic agents.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×